Epidemiology and Outcomes of Bloodstream Infections in Patients in a Burns Intensive Care Unit: An 8-Year Retrospective Study - Summary - MDSpire

Epidemiology and Outcomes of Bloodstream Infections in Patients in a Burns Intensive Care Unit: An 8-Year Retrospective Study

  • By

  • Héloïse Petit

  • Christian de Tymowski

  • Emmanuel Dudoignon

  • Mathilde Liberge

  • Jean-Luc Donay

  • Maite Chaussard

  • Maxime Coutrot

  • Alexandru Cupaciu

  • Lucie Guillemet

  • Benjamin Deniau

  • Alexandre Pharaboz

  • Mourad Benyamina

  • Blandine Denis

  • Guillaume Mellon

  • Matthieu Lafaurie

  • Alexandre Alanio

  • François Dépret

  • Béatrice Berçot

  • François Caméléna

  • March 12, 2025

  • 0 min

Share

Objective:

To analyze the epidemiology and risk factors for bloodstream infections (BSIs) in patients admitted to a burns intensive care unit (BICU) over an eight-year period, highlighting the significance of BSIs in this vulnerable population.

Key Findings:
  • 21% of patients developed BSIs, with higher rates in older patients and those with larger burn areas, indicating a need for targeted interventions.
  • Gram-positive pathogens were most common in the first week, while MDR Pseudomonas aeruginosa increased after 15 days, suggesting a shift in infection management strategies.
  • A significant decrease in Acinetobacter baumannii rates and an increase in MDR P. aeruginosa rates were observed after 2015, highlighting the evolving nature of infection threats.
Interpretation:

The study highlights the persistent risk of BSIs in burn patients, emphasizing the need for tailored antimicrobial therapy based on local epidemiology and the implications for clinical practice.

Limitations:
  • Single-center study may limit generalizability.
  • Retrospective design may introduce biases in data collection.
  • Potential for unmeasured confounding factors affecting outcomes.
Conclusion:

Understanding the epidemiology of BSIs in BICUs is crucial for effective sepsis management and infection prevention strategies, with a call for ongoing surveillance and adaptation of treatment protocols.

Original Source(s)

Related Content